30

Tianjin Ringpu Bio-Technology Co LtdSHE 300119 Stock Report

Last reporting period 30 Sep, 2023

Updated 14 Nov, 2024

Last price

Market cap $B

0.439

Micro

Exchange

XSHE - Shenzhen Stock Exchange

300119.SZ Stock Analysis

30

Neutral

Based on Eyestock quantitative analysis, 300119.SZ`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

66/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

16.2 %

Greatly undervalued

Market cap $B

0.439

Dividend yield

4.10 %

Shares outstanding

466.13 B

Tianjin Ringpu Bio-technology Co., Ltd. engages in the provision of animal health services. The company is headquartered in Tianjin, Tianjin and currently employs 2,701 full-time employees. The company went IPO on 2010-09-17. The firm operates through two main segments. The Veterinary Use Biological Products segment is mainly involved in the manufacture and sales of poultry vaccines, veterinary use vaccines, biological products for treatment, diagnostic products and other biological products. The Veterinary Preparations segment is mainly involved in the manufacture and sales of chemical preparations, veterinary Chinese medicine and other preparations.

View Section: Eyestock Rating